No results for ‘’
Trident Texofab Ltd
₹22.30
(3.34%)
Mon, 21 Sept 2026, 07:58 pm
Process Industries
Textiles
24.5KTrident Texofab EV/EBITDA Ratio
| Particulars | 2019 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Price to earnings ratio | 48.20 | 26.12 | 45.52 | 81.46 |
| Price to book ratio | 3.49 | 3.82 | 3.02 | 5.02 |
| Price to sales ratio | 0.46 | 0.60 | 0.49 | 1.68 |
| Price to cash flow ratio | 0 | 22.52 | 0 | 0 |
| Enterprise value | 64.25Cr | 95.65Cr | 89.12Cr | 231Cr |
| Enterprise value to EBITDA ratio | 14.06 | 15.16 | 14.51 | 42.20 |
| Debt to equity ratio | 1.93 | 2.49 | 2.47 | 0.63 |
| Return on equity % | 0 | 0 | 6.87 | 7.91 |
Trident Texofab Ltd Enterprise Value to EBITDA Ratio
The Trident Texofab Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Trident Texofab Ltd's valuation, profitability, and overall financial performance. Tracking the Trident Texofab Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Trident Texofab Ltd (NSE: , BSE: 540726) is currently trading at ₹22.30, with a market capitalization of ₹33.32Cr. As a leading company in the Process industries sector and Textiles industry, monitoring the Trident Texofab Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Trident Texofab Ltd Enterprise Value to EBITDA Ratio Current Value
The current Trident Texofab Ltd Enterprise Value to EBITDA Ratio stands at 42.20.
The latest Trident Texofab Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Trident Texofab Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Trident Texofab Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 42.20
- 2023: 14.51
- 2022: 15.16
- 2019: 14.06
The recent rise in Trident Texofab Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.
What Trident Texofab Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Trident Texofab Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Trident Texofab Ltd.
Trident Texofab Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Trident Texofab Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Trident Texofab Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Trident Texofab Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.